webinar register page

Management of High-Risk Thyroid Cancer
Join us for a virtual CME on high risk thyroid cancer which remains a therapeutic challenge. This live, case-based panel discussion will cover the basics of high risk thyroid cancer from presentation and diagnosis to treatment. A comprehensive discussion on standard and advanced therapeutics will be included. The necessity of a multi-d advanced care team for the mgmt. of these patients will be emphasized.

Moderated by Susan Mandel, MD, the panel will include specialists from medical oncology, surgery, radiation oncology and nuclear medicine.

‣Understand the approaches for radioactive iodine therapy in aggressive thyroid cancer
‣Identify clinical scenarios where external beam radiation may be indicated
‣Gain familiarity with surveillance strategies for high-risk patients and indications for intervention
‣Recognize the role of systemic therapy in metastatic thyroid cancer

Marcia Brose, MD, PhD
Director of the Thyroid Cancer Therapeutics Program
Medical Oncology

Ara Chalian, MD
Director of Facial Plastic Surgery, Head and Neck Surgery

Samuel Swisher-McClure, MD, MSHP
Co-Director, Head & Neck Cancer Service Line
Radiation Oncology

Daniel Pryma, MD
Chief, Division of Nuclear Medicine Imaging and Therapy

In support of improving patient care, Penn Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physicians: Penn Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits(TM). Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AMA PRA Category 1 Credits™ (1.00 hours), Non-Physician Attendance / Participation (1.00 hours)

May 4, 2021 07:00 AM in Eastern Time (US and Canada)

Webinar logo
* Required information

By registering, I agree to the Privacy Statement and Terms of Service.